ÇALIŞKAN, B. Et Al. 2016. Discovery of 4 5 Diarylisoxazol 3 Carboxylic Acid Skeleton as a Novel Chemotype for Inhibition of 5 Lipoxygenase Activating Proteın FLAP. EFMC International Symposium on Medicinal Chemistry 2016 , (Manchester, United Kingdom).

ÇALIŞKAN, B., ÇELİKOĞLU, E., GERSTMEIER, J., VOELKER, S., GARSCHA, U., OLĞAÇ, A., ... CAROTTI, A.(2016). Discovery of 4 5 Diarylisoxazol 3 Carboxylic Acid Skeleton as a Novel Chemotype for Inhibition of 5 Lipoxygenase Activating Proteın FLAP . EFMC International Symposium on Medicinal Chemistry 2016, Manchester, United Kingdom

ÇALIŞKAN, BURCU Et Al. "Discovery of 4 5 Diarylisoxazol 3 Carboxylic Acid Skeleton as a Novel Chemotype for Inhibition of 5 Lipoxygenase Activating Proteın FLAP," EFMC International Symposium on Medicinal Chemistry 2016, Manchester, United Kingdom, 2016

ÇALIŞKAN, BURCU Et Al. "Discovery of 4 5 Diarylisoxazol 3 Carboxylic Acid Skeleton as a Novel Chemotype for Inhibition of 5 Lipoxygenase Activating Proteın FLAP." EFMC International Symposium on Medicinal Chemistry 2016 , Manchester, United Kingdom, 2016

ÇALIŞKAN, B. Et Al. (2016) . "Discovery of 4 5 Diarylisoxazol 3 Carboxylic Acid Skeleton as a Novel Chemotype for Inhibition of 5 Lipoxygenase Activating Proteın FLAP." EFMC International Symposium on Medicinal Chemistry 2016 , Manchester, United Kingdom.

@conferencepaper{conferencepaper, author={BURCU ÇALIŞKAN Et Al. }, title={Discovery of 4 5 Diarylisoxazol 3 Carboxylic Acid Skeleton as a Novel Chemotype for Inhibition of 5 Lipoxygenase Activating Proteın FLAP}, congress name={EFMC International Symposium on Medicinal Chemistry 2016}, city={Manchester}, country={United Kingdom}, year={2016}}